Skip to content

Recurrent ovarian endometriotic cysts: single-port laparoscopic sclerotherapy with laparoscopy

Recurrent ovarian endometriotic cysts: single-port laparoscopic sclerotherapy with laparoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055188
Enrollment
Unknown
Registered
2022-01-02
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent ovarian endometriosis cyst

Interventions

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-40 years; 2. Unilateral or bilateral recurrent ovarian endometriosis, transvaginal ultrasonography, cyst diameter of 3-10 cm, excluding physiological cysts; 3. Tumor marker CA125<200IU/mL, HE4<70 pm; 4. All patients signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Evidence of polycystic ovary syndrome, evidence of premature ovarian failure (follicle-stimulating hormone >= 40 IU/L), endocrine diseases that may affect ovarian function (such as thyroid dysfunction, hyperprolactinemia); 2. Hormone drugs (such as oral contraceptives, gonadotropin-releasing hormone analogs) have been taken within 3 months before surgery; 3. Tumor markers, ultrasound, MRI suggest possible ovarian malignant disease; 4. Poor cardiopulmonary function, unable to tolerate laparoscopic surgery or have other surgical contraindications; 5. Those who are allergic to MRI contrast agents and cannot complete relevant examinations.

Design outcomes

Primary

MeasureTime frame
Sex hormone;Anti-mullerian hormone;Ultrasound to monitor the number of follicles;Treatment outcome within 1 year after surgery (recurrence or not);

Countries

China

Contacts

Public ContactDeng Youlin

The First Affiliated Hospital of Chongqing Medical University

1098497820@qq.com+86 13594065232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026